Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Epidermal growth factor receptor in human breast cancers: Correlation with estrogen and progesterone receptors

    Epidermal growth factor receptor (EGFR), determined by the Scatchard curve method, was found in 22 cases of a random series of 100 patients with breast carcinoma. Two groups of patients were identified, one (n...

    J. C. Delarue, S. Friedman, H. Mouriesse in Breast Cancer Research and Treatment (1988)

  2. No Access

    Chapter and Conference Paper

    Risk Factors of Pulmonary Complications Following Esophagectomy in Carcinoma of the Esophagus: Results of the Prospective Study Conducted by the OESO Group

    Surgical resection of cancer of the esophagus is associated with a high complication rate: mainly leakage of the anastomotic site and pulmonary complications. Mortality following postoperative pulmonary compli...

    A. Elman, R. Giuli, H. Sancho-Garnier in Diseases of the Esophagus (1988)

  3. No Access

    Chapter

    IgA/EA: Prognosis Marker for Relapse among NPC Patients with Complete Remission after Radiotherapy

    A longitudinal multicenter study on nasopharyngeal carcinoma (NPC) was initiated in 1979, with the aim of evaluating the EBV antibody response at various postradiotherapy follow-ups for predicting the long-ter...

    G. de-The, F. de Vathaire, H. Sancho-Garnier in Epstein-Barr Virus and Human Disease (1987)

  4. No Access

    Chapter

    HLA -A, -B and -DR Antigens in North African Patients with Nasopharyngeal Carcinoma

    An increased risk for nasopharyngeal carcinoma (NPC) has been reported by Simons in 1976 for Chinese individuals simultaneously expressing HLA-A2 and B-Sin-2 (Bw46) antigens.

    F. de Vathaire, P. Herait, M. Lipinski in Epstein-Barr Virus and Human Disease (1987)

  5. No Access

    Chapter

    Skin Tumours

    We have classified the cutaneous tumours that occur in children as follows:

    H. Sancho-Garnier, M. F. Avril in Cancer in Children (1986)

  6. No Access

    Chapter

    Inflammatory Tumors of the Human Breast: Determination of Estrogen and Progesterone Receptors

    The clinically inflammatory tumors are considered to be very severe carcinomas characterized by a particularly low rate of survival at 5 years [6, 14]. In the present study, we have simultaneously determined e...

    G. Contesso, F. May-Levin, J. C. Delarue in Clinical Interest of Steroid Hormone Recep… (1984)

  7. No Access

    Chapter

    Follow-Up Results from a Randomized Trial for T3 and T4 Breast Cancer Patients: Previous BCG Immunotherapy Improves Response to Chemotherapy in the Relapse Patient

    Following locoregional treatment, patients were randomized into three groups: The first group received no complementary treatment; the second group received adjuvant chemotherapy (vincristine, cyclophosphamide...

    B. Serrou, H. Sancho-Garnier, P. Cappelaere, R. Plagne in Adjuvant Therapies of Cancer (1982)

  8. No Access

    Article

    Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast

    Oestrogen (RE) and progesterone (RP) cytosolic receptors have been studied in 59 clinically inflammatory tumours of the human breast. The results were compared to those obtained in a series of 496 operable tum...

    J C Delarue, F May-Levin, H Mouriesse, G Contesso in British Journal of Cancer (1981)

  9. No Access

    Chapter

    First Results of a Randomized Trial on Immunotherapy of Head and Neck Tumors

    Trials of active nonspecific immunotherapy as adjuvant therapy for tumors have increased dramatically in number since the results that have been published on acute leukemia [6] and melanoma [3, 5, 7–9]. In spi...

    J. L. Amiel, H. Sancho-Garnier in Adjuvant Therapies and Markers of Post-Sur… (1979)

  10. No Access

    Chapter

    Results of a Randomized Trial of Prophylactic Chemotherapy in T3-T4 Breast Cancer Patients Previously Treated by Radiotherapy

    The goal of this study was to evaluate results obtained with complementary chemotherapy administered to women with locally evolved breast cancer compared with those obtained in patients receiving simple immuno...

    B. Serrou, H. Sancho-Garnier, P. Cappelaere in Adjuvant Therapies and Markers of Post-Sur… (1979)

  11. No Access

    Chapter

    EORTC/GTO Adjuvant Chemotherapy Program for Primary Ewing’s Sarcoma: Results at 5 Years

    Ewing’s sarcoma is classically linked with a very poor prognosis after a local surgical treatment and/or radiotherapy: 5-year survival is less than 15% [1]. The recent progress made in chemotherapy had led to ...

    B. P. Le Mevel, B. Hoerni, D. Durant in Adjuvant Therapies and Markers of Post-Sur… (1979)

Page of 2 next disabled